Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
3. TAVI: St. Jude Medical wins CE Mark for new Portico sizes
St. Jude Medical said that it won CE Mark approval in the European Union 2 new, larger sizes of its Portico replacement heart valve.
Little Canada, Minn.-based St. Jude said the approval covers the 27mm and 29mm sizes of the Portico transcatheter aortic valve implant. The 23mm Portico version won CE Mark approval in November 2012, with the 25mm version following suit in December 2013. Read more
2. Plaintiff takes Infuse case against Medtronic to the Supreme Court
The plaintiff in a product liability lawsuit asked the U.S. Supreme Court to take up the case, involving alleged off-label promotion of Medtronic’s controversial Infuse bone-growth protein.
Patricia Caplinger wants the high court to review an April decision by the U.S Court of Appeals for the 10th Circuit that her state-law tort claims are preempted by federal law. Caplinger had argued that her claims survived preemption because the device was used in a manner not approved by the Food & Drug Administration. Read more
1. Penumbra prices $120 million initial public offering
Penumbra priced its initial public offering, saying it plans to raise $120 million by floating 4 million shares at $30 apiece.
The company is also offering a 30-day underwriters option for an additional 600,000 shares. Penumbra shares are slated to trade on the New York Stock Exchange today under the “PEN” symbol. Read more